Skip to main content
MedPacto, Inc. logo

MedPacto, Inc. — Investor Relations & Filings

Ticker · 235980 ISIN · KR7235980000 KO Manufacturing
Open in API
Filings indexed 262 across all filing types
Latest filing 2022-12-15 Regulatory Filings
Country KR South Korea
Listing KO 235980

About MedPacto, Inc.

http://www.medpacto.com/eng/

MedPacto, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of first-in-class therapies. The company leverages a biomarker-driven and genome-based platform to create personalized treatments, aiming to advance precision medicine. Its primary therapeutic areas include oncology and autoimmune diseases, with pipeline expansion into metabolic and bone joint disorders. MedPacto's research focuses on novel mechanisms, such as modulating the tumor microenvironment, to address incurable diseases and overcome the limitations of existing treatments.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal notice of the procedural steps required for the meeting. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS category.
2022-12-15 Korean
투자판단관련주요경영사항(재발성, 불응성 또는 진행성 골육종 환자 대상 백토서팁 단독 요법 제1/2상 임상시험계획(IND) 한국 식약처(MFDS) 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from MedPacto regarding the submission of an Investigational New Drug (IND) application to the Korean Ministry of Food and Drug Safety (MFDS) for a clinical trial. It is a standard corporate disclosure of a material event (clinical trial application). Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a formal regulatory announcement of a business development, it falls under the 'Regulatory Filings' category.
2022-11-21 Korean
기타경영사항(자율공시)(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) filed by MedPacto regarding the acquisition of a patent for a cancer diagnostic method. It details the patent title, content, and utilization plan. Since this is a regulatory announcement regarding a specific corporate event (patent acquisition) that does not fit into financial reporting, governance, or shareholder meeting categories, it is classified as a general regulatory filing.
2022-11-16 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 메드팩토' (MedPacto, Inc.) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-11 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange by MedPacto. This document details the issuance of stock options to employees, including the number of shares, exercise price, and valuation methodology. Since this relates to the issuance of new shares or capital-related instruments (stock options), it falls under the category of share issues or capital changes.
2022-09-29 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose, and method of the meeting. Crucially, it states that the actual IR materials will be available for download on the KRX KIND system on the day of the event. Since this document is an announcement of an event and the future availability of materials rather than the presentation itself, it falls under the category of a regulatory announcement regarding report/material publication.
2022-09-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.